Apolipoprotein E and Alzheimer Disease The apo-e4 allele of apolipoprotein E has recently been found to be in striking genetic disequilibrium with the development of Alzheimer's disease (AD) in patients with late onset familial AD (Strittmatter et al., 1993). This observation has been extended by our own data and at least 4 independent groups to show that apo-e4 is found at a much higher than expected frequency in sporadic AD as well, and apo-E4 has accordingly been suggested to be an heritable risk factor for AD. Neuroanatomical, biochemical and molecular biological tools will be used to gain insight into the biological factors that mediate this increased risk. The results suggest one of two possibilities: either the apo-E4 protein interacts with pathophysiological processes to affect the course or likelihood of AD, or the apo-e4 allele is a genetic marker suggesting the presence of a causative or susceptibility factor nearby. Both possibilities will be explored; emerging evidence of biological interactions between apo-E and AB, a molecule firmly established as playing a role in AD, favors the first possibility. The working model is that apo-E binds AB in the neuropil, and transports it to apo-E receptors that are linked to clathrin coated pits for subsequent metabolism. The investigator hypothesizes that apo-E4 protein performs this """"""""clearing"""""""" function less well than apo-E3. Already preliminary data support key features of this model: The investigator has confirmed genetic disequilibrium of apo-E4 and AD in an autopsy confirmed population of sporadic AD. The investigator also found that the amount of AB deposition is related to apo-E genotype, increasing from 3/3 to 3/4 to 4/4. Apo-E immunostains senile plaques (SP) in AD brains. Low density lipoprotein receptor related protein (LRP) immunostaining colocalizes with apo-E on SP, placing this apo-E receptor in close proximity to AB and apo-E. The investigator has developed in vitro models to study these interactions. Using ligand blots they have found specific and high affinity binding of AB to apo-E with Kd in the 10-20 Nm range. Furthermore, they have preliminary data using fibroblasts that express a high amount of LRP support the idea of cellular uptake of AB complexes in vitro. The investigator will characterize this uptake and study the cellular consequences and metabolism of AB. The application has 3 major aims: (1) to investigate the anatomical relationship among apo-E, its receptors, and AB deposition in AD brain tissue; (2) to investigate the interaction of AB with apo-E3 and apo-E4 in vitro. Determine if apo-E facilitates AB uptake or binding to cells in culture via LRP or other members of the LDL receptor family; and (3) to test the hypothesis that amount of apo-E4 expression is related to degree of Alzheimer neuropathological change or risk for dementia. These experiments will study the role apo-E and its receptors play in the pathophysiology of AD, and explore biological mechanisms that may underlie the increased risk for AD mediated by apo-e4.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
5R01AG012406-05
Application #
2732556
Study Section
Neurological Sciences Subcommittee 1 (NLS)
Project Start
1994-09-01
Project End
2000-01-31
Budget Start
1998-07-01
Budget End
2000-01-31
Support Year
5
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Beyer, Anja-Silke; von Einem, Bjoern; Schwanzar, Daniel et al. (2012) Engulfment adapter PTB domain containing 1 interacts with and affects processing of the amyloid-ýý precursor protein. Neurobiol Aging 33:732-43
Hashimoto, Tadafumi; Serrano-Pozo, Alberto; Hori, Yukiko et al. (2012) Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid ýý peptide. J Neurosci 32:15181-92
Koffie, Robert M; Hashimoto, Tadafumi; Tai, Hwan-Ching et al. (2012) Apolipoprotein E4 effects in Alzheimer's disease are mediated by synaptotoxic oligomeric amyloid-?. Brain 135:2155-68
Hashimoto, Tadafumi; Adams, Kenneth W; Fan, Zhanyun et al. (2011) Characterization of oligomer formation of amyloid-beta peptide using a split-luciferase complementation assay. J Biol Chem 286:27081-91
Koffie, Robert M; Farrar, Christian T; Saidi, Laiq-Jan et al. (2011) Nanoparticles enhance brain delivery of blood-brain barrier-impermeable probes for in vivo optical and magnetic resonance imaging. Proc Natl Acad Sci U S A 108:18837-42
Spoelgen, R; Adams, K W; Koker, M et al. (2009) Interaction of the apolipoprotein E receptors low density lipoprotein receptor-related protein and sorLA/LR11. Neuroscience 158:1460-8
Hoe, Hyang-Sook; Fu, Zhanyan; Makarova, Alexandra et al. (2009) The effects of amyloid precursor protein on postsynaptic composition and activity. J Biol Chem 284:8495-506
Jones, Phillip B; Rozkalne, Aneta; Meyer-Luehmann, Melanie et al. (2008) Two postprocessing techniques for the elimination of background autofluorescence for fluorescence lifetime imaging microscopy. J Biomed Opt 13:014008
von Arnim, Christine A F; Spoelgen, Robert; Peltan, Ithan D et al. (2006) GGA1 acts as a spatial switch altering amyloid precursor protein trafficking and processing. J Neurosci 26:9913-22
Spoelgen, Robert; von Arnim, Christine A F; Thomas, Anne V et al. (2006) Interaction of the cytosolic domains of sorLA/LR11 with the amyloid precursor protein (APP) and beta-secretase beta-site APP-cleaving enzyme. J Neurosci 26:418-28

Showing the most recent 10 out of 58 publications